Brief: POINT Biopharma Makes Strategic Investment In Commercial-Scale Alpha-Emitting Isotope Manufacturer

POINT Biopharma Global

15/05/2023 12:56

May 15 (Reuters) - POINT Biopharma Global Inc  PNT.O :
    * POINT BIOPHARMA MAKES STRATEGIC INVESTMENT IN
COMMERCIAL-SCALE
ALPHA-EMITTING ISOTOPE MANUFACTURER
    * POINT BIOPHARMA GLOBAL INC -  ANNOUNCED COLLABORATION TO
CREATE
IONETIX ALPHA CORP. WITH IONETIX CORPORATION
    * POINT BIOPHARMA GLOBAL INC - IONETIX HAS TRANSFERRED ITS
ALPHA
THERAPY ISOTOPE BUSINESS ASSETS INTO IONETIX-
    * POINT BIOPHARMA GLOBAL INC - WILL INVEST $10 MILLION INTO
IONETIX-

Source text for Eikon:  ID:nGNX8gpNGh 
Further company coverage:  PNT.O 

 ((Reuters.Brief@thomsonreuters.com;))